The technology employs CRISPR/Cas9 mutagenesis to create genetically modified mice that express truncated versions of the Tim-3 protein under the control of its native promoter. The modifications are maintained on a pure C57BL/6 genetic background, ensuring physiological expression levels. The mice are viable, fertile, and adhere to Mendelian inheritance ratios. This refined model exhibits Tim-3 expression solely as the truncated variant on immune cell surfaces, offering a precise tool for studying Tim-3 signaling in diverse immune response contexts without the interference of wild-type protein.